作者
Trevor Simard,Richard G. Jung,Kyle Lehenbauer,Kerstin Piayda,Radosław Pracoń,Gregory Jackson,Eduardo Flores‐Umanzor,Laurent Faroux,Kasper Korsholm,K.R. Julian Chun,Shaojie Chen,Moniek Maarse,Kristi Montrella,Zakeih Chaker,Jocelyn N. Spoon,Luigi Emilio Pastormerlo,Felix Meincke,Abhishek C. Sawant,Carmen Moldovan,Mohammed Qintar,Mehmet K. Aktaş,Luca Branca,Andrea Radinovic,Pradhum Ram,Rayan El‐Zein,Thomas Flautt,Wern Yew Ding,Bassel Sayegh,Tomas Benito‐González,Oh‐Hyun Lee,Solomon O. Badejoko,Christina Paitazoglou,Nabeela Karim,Ahmed M. Zaghloul,Himanshu Agrawal,Rachel M. Kaplan,Oluseun Alli,Aamir Ahmed,Hussam Suradi,Bradley P. Knight,Venkata Alla,Sidakpal Panaich,Tom Wong,Martin Bergmann,Rashaad Chothia,Jung‐Sun Kim,Armando Pérez de Prado,Raveen Bazaz,Dhiraj Gupta,Miguel Valderrábano,Carlos E. Sanchez,Mikhael F. El‐Chami,Patrizio Mazzone,Marianna Adamo,Fred S. Ling,Dee Dee Wang,William W. O’Neill,Wojciech Wojakowski,Ashish Pershad,Sérgio Berti,Daniel B. Spoon,Akram Kawsara,George Jabbour,Lucas V.A. Boersma,Boris Schmidt,Jens Erik Nielsen‐Kudsk,Josep Rodés‐Cabau,Xavier Freixa,Christopher R. Ellis,Laurent Fauchier,Marcin Demkow,Horst Sievert,Michael L. Main,Benjamin Hibbert,David R. Holmes,Mohamad Alkhouli
摘要
Device-related thrombus (DRT) has been considered an Achilles' heel of left atrial appendage occlusion (LAAO). However, data on DRT prediction remain limited.This study constructed a DRT registry via a multicenter collaboration aimed to assess outcomes and predictors of DRT.Thirty-seven international centers contributed LAAO cases with and without DRT (device-matched and temporally related to the DRT cases). This study described the management patterns and mid-term outcomes of DRT and assessed patient and procedural predictors of DRT.A total of 711 patients (237 with and 474 without DRT) were included. Follow-up duration was similar in the DRT and no-DRT groups, median 1.8 years (interquartile range: 0.9-3.0 years) versus 1.6 years (interquartile range: 1.0-2.9 years), respectively (P = 0.76). DRTs were detected between days 0 to 45, 45 to 180, 180 to 365, and >365 in 24.9%, 38.8%, 16.0%, and 20.3% of patients. DRT presence was associated with a higher risk of the composite endpoint of death, ischemic stroke, or systemic embolization (HR: 2.37; 95% CI, 1.58-3.56; P < 0.001) driven by ischemic stroke (HR: 3.49; 95% CI: 1.35-9.00; P = 0.01). At last known follow-up, 25.3% of patients had DRT. Discharge medications after LAAO did not have an impact on DRT. Multivariable analysis identified 5 DRT risk factors: hypercoagulability disorder (odds ratio [OR]: 17.50; 95% CI: 3.39-90.45), pericardial effusion (OR: 13.45; 95% CI: 1.46-123.52), renal insufficiency (OR: 4.02; 95% CI: 1.22-13.25), implantation depth >10 mm from the pulmonary vein limbus (OR: 2.41; 95% CI: 1.57-3.69), and non-paroxysmal atrial fibrillation (OR: 1.90; 95% CI: 1.22-2.97). Following conversion to risk factor points, patients with ≥2 risk points for DRT had a 2.1-fold increased risk of DRT compared with those without any risk factors.DRT after LAAO is associated with ischemic events. Patient- and procedure-specific factors are associated with the risk of DRT and may aid in risk stratification of patients referred for LAAO.